2025年5月18日 周日
Home > Archive>Volume 25, Issue 1, 2017 >99-104
PDF HTML XML Export Cite reminder
Research progress of Buyanghuanwu decoction on mechanism of anti-atherosclerosis
Author:
Affiliation:

1.Nanjing University of Chinese Medicine, ;2.Basic Laboratory of Encephalopathy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 201602, China)

Clc Number:

R28

  • Article
    • | |
  • Metrics
    • |
  • Reference [61]
    • | | | |
  • Comments
    Abstract:

    Buyanghuanwu decoction is a traditional formula which has good efficiency on the prevention and treatment of atherosclerosis, but its mechanism is still obscure. This paper summarized the Buyanghuanwu decoction’s mechanism on signaling pathway of aththerosclerosis including inflammatory pathway, Rho/Rho kinase signaling pathway, Toll like receptor signaling pathway, matrix metalloproteinases signaling pathway and so on.

    Reference
    [1] Libby P.Atherosclerosis in inflammation.Nature, 2,0(6917):868-874.
    [2] 刘俊娥, 张继平.补阳还五汤药效物质基础的研究进展.中医药信息, 2,9(5):117-119.
    [3] 张风芹, 葛向党, 张艳, 等.益气活血中药和辛伐他汀西药对球囊损伤后动脉粥样硬化家兔血管内皮功能的影响.中华中医药学刊, 2,0(5):1 033-036.
    [4] 侯秀娟.补阳还五汤治疗冠状动脉粥样硬化性心脏病心绞痛临床研究.中医学报, 3,8(3):405-406.
    [5] 龚道凯, 张学敏.补阳还五汤对脑卒中患者血脂及动脉粥样硬化的影响.中国实用神经疾病杂志, 3,6(24):20-22.
    [6] 夏丽女, 罗琳娜, 陈文华.阿托伐他汀联合补阳还五汤治疗颈动脉粥样硬化彩色多普勒超声疗效观察.新中医, 5,7(3):37-38.
    [7] 王晚霞, 李荣亨.补阳还五汤作用机制研究进展.中西医结合心脑血管病杂志, 8,6(5):574-576.
    [8] 姚晖, 张继平.补阳还五汤抗血栓实验研究进展.中国中医药信息杂志, 6,3(5):95-97.
    [9] 刘俊田.动脉粥样硬化发病的炎症机制的研究进展.西安交通大学学报(医学版), 5,6(2):141-152.
    [10] Sen R, Baltimore D.Inducibility of kappa immunoglobulin enhancer-binding protein NF-kappa B by a posttranslational mechanism.Cell, 7,7(6):921-928.
    [11] Perkins ND.Integrating cell-signalling pathways with NF-kappaB and IKK function.Nat Rev Mol Cell Biol, 7,8(1):49-62.
    [12] Karin M, Ben-Neriah Y.Phosphorylation meets ubiquitination:the control of NF-kappaB activity.Annu Rev Immunol, 0,8(1):621-663.
    [13] Mémet S.NF-kappaB functions in the nervous system:from development to disease.Biochem Pharmacol, 6,2(9):1 180-195.
    [14] Gutierrez H, Davies AM.Regulation of neural process growth, elaboration and structural plasticity by NF-κB.Trends Neurosci, 1,4(6):316-325.
    [15] Ferran C, Millan MT, Csizmadia V, et al.Inhibition of NF-κB by pyrrolidine dithiocarbamate blocks endothelial cell activation.Biochem Biophys Res Commun, 5,4(1):212-223.
    [16] 张红珍, 李丽, 焦瑞, 等.补阳还五汤对动脉粥样硬化模型大鼠主动脉Rho激酶及NF-κB p65 mRNA表达的影响.中国中西医结合杂志, 5,5(12):1 495-500.
    [17] Auyeung KKW, Woo CWH, Sung FL, et al.Hyperhomocysteinemia activates nuclear factor-κB in endothelial cells via oxidative stress.Circ Res, 4,4(1):28-36.
    [18] 刘玉晖, 邱顺辉, 游宇, 等.补阳还五汤抗Hcy致动脉硬化作用与调控核因子-κB活性相关性的研究.中国药学杂志, 2,7(2):104-108.
    [19] Chang L, Karin M.MAP kinase signalling cascades.Nature, 1,0(6824):37-40.
    [20] Maccorkle RA, Tan TH.Mitogen-activated protein kinases in cell-cycle control.Cell Biochem Biophys, 5,3(3):451-61.
    [21] Chen JY, Wang C, Wang J, et al.The advanves of MAPK signaling pathway.Chin Med Pharm, 1,1(8):32-34.
    [22] 卢琼, 谭睿, 崔文婷, 等.细胞信号通路与动脉粥样硬化.中国医药生物技术, 2,7(3):211-215.
    [23] Hsieh CC, Kuro-OM, Rosenblatt KP, et al.The ASK1-signalosome regulates p38 MAPK activity in response to levels of endogenous oxidative stress in the Klotho mouse models of aging.Aging, 0,2(9):597-611.
    [24] Hsieh HL, Wang HH, Wu WB, et al.Transforming growth factor-β1 induces matrix metalloproteinase-9 and cell migration in astrocytes:roles of ROS-dependent ERK- and JNK-NF-κB pathways.J Neuroinflammation, 0,7(2):88.
    [25] Brisset AC, Isakson BE, Kwak ABR.Connexins in vascular physiology and pathology.Antioxid Redox Signal, 9,1(2):267-282.
    [26] 邱顺辉, 章常华, 高书亮, 等.补阳还五汤抗动脉粥样硬化与间隙连接蛋白关系的研究.中国实验方剂学杂志, 1,7(18):161-165.
    [27] 韦柳霞, 朱继金.T细胞活化及共刺激分子信号转导与动脉粥样硬化的关系.医学信息旬刊, 0,5(2):438-439.
    [28] Gotsman I, Sharpe AH, Lichtman AH.T-cell costimulation and coinhibition in atherosclerosis.Circ Res, 8,3(11):1 220-231.
    [29] Pi X, Lockyer P, Dyer LA, et al.Bmper inhibits endothelial expression of inflammatory adhesion molecules and protects against atherosclerosis.Arterioscler Thromb Vasc Biol, 2,2(9):2 214-222.
    [30] 吕永恒, 黎洪展, 肖卫辉, 等.补阳还五汤对动脉粥样硬化大鼠细胞间黏附分子-1表达的影响.中国老年学杂志, 5,5(17):4 772-774.
    [31] 张红珍, 陈燕清, 耿艳军.动脉粥样化模型大鼠主动脉血管细胞黏附分子1 mRNA表达与补阳还五汤的干预.中国组织工程研究, 2,6(15):2 776-779.
    [32] 张红珍, 李丽, 焦瑞, 等.补阳还五汤对动脉粥样硬化模型炎症因子调控的作用.中药药理与临床, 5,1(2):152-153.
    [33] Hashimoto C, Hudson KL, Anderson KV.The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity appears to encode a transmembrane protein.Cell, 8,2(2):269-279.
    [34] 王笑梅, 司良毅.Toll受体与动脉粥样硬化的关系研究进展.第三军医大学学报, 5,7(10):1 055-056.
    [35] Medzhitov R, Preston-Hurlburt P, Janeway CA Jr.A human homologue of the Drosophila Toll protein signals activation of adaptive immunity.Nature, 7,8(6640):394-397.
    [36] Poltorak A, He X, Smirnova I, et al.Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice:mutations in Tlr4 gene.Science, 8,2(5396):2 085-088.
    [37] 杨安强, 陈礼刚.Toll样受体4的研究进展.泸州医学院学报, 1,4(3):306-308.
    [38] 李卿姬, 姜华, 姜玉姬.补阳还五汤含药血清对Toll样受体4信号转导通路及氧化低密度脂蛋白受体-1表达的影响.中国实验方剂学杂志, 2,8(6):155-158.
    [39] 范丽菲, 闫慧娟, 莫日根.Rho小G蛋白介导细胞周期调控.中国生物化学与分子生物学报, 3,9(7):619-628.
    [40] Satoh K, Fukumoto Y, Shimokawa H.Rho-kinase:important new therapeutic target in cardiovascular diseases.Am J Physiol Heart Circ Physiol, 1,1(2):287-296.
    [41] Spiering D, Hodgson L.Dynamics of the Rho-family small GTPases in actin regulation and motility.Cell Adh Migr, 1,5(2):48-50.
    [42] 孙倩倩, 吉爱国.ROCK与动脉粥样硬化.生命的化学, 3,3(6):690-694.
    [43] 刘志勇, 游宇, 易文凤, 等.补阳还五汤通过调节HUVEC细胞Rho/Rho激酶信号通路作用于动脉粥样硬化的研究.中药新药与临床药理, 5,6(5):595-600.
    [44] 刘玉晖, 易文凤, 游宇.补阳还五汤抗动脉粥样硬化作用与紧密连接蛋白的关系.中国实验方剂学杂志, 4,0(24):155-159.
    [45] 张红珍, 李丽, 焦瑞, 等.补阳还五汤对动脉粥样硬化模型主动脉Rho激酶PAl-1及eNOS mRNA表达的影响.中国实验方剂学杂志, 5,1(16):110-114.
    [46] 石健, 侯静波.基质金属蛋白酶与动脉粥样硬化关系研究新进展.国际心血管病杂志, 3,0(1):25-27.
    [47] Karki R, Sahi N, Jeon ER, et al.Chungtaejeon a Korean fermented tea scavenges oxidation and inhibits cytokine induced proliferation and migration of human aortic smooth muscle cells.Plant Foods for Human Nutrition, 1,6(1):27-33.
    [48] Robertson L, Grip L, Hultén LM, et al.Release of protein as well as activity of MMP-9 from unstable atherosclerotic plaques during percutaneous coronary intervention.J Intern Med, 7,2(6):659-667.
    [49] 王腾玉, 彭成海.基质金属蛋白酶及其抑制剂与动脉粥样硬化斑块稳定性的关系研究进展.中国综合临床, 2,8(9):997-999.
    [50] 杨粉娣, 郭姣.基质金属蛋白酶与动脉粥样硬化斑块稳定性的关系研究进展.实用医学杂志, 1,7(21):3 981-983.
    [51] 张红珍, 李丽, 刘亚明.补阳还五汤对动脉粥样硬化模型主动脉基质金属蛋白酶表达量的影响.中国中医急症, 8,7(5):649-651.
    [52] Cherry PD, Furchgott RF, Zawadski JV, et al.Role of endothelial cells in relaxation of isolated arteries by bradykinin.Proc Natl Acad Sci USA, 2,9:2 106-110.
    [53] Palmer RMJ, Ferrige AG, Moncada SA.Nitric oxide release accounts for the biological activity of endothelial-derived relaxing factor.Nature, 7,7(6122):524-526.
    [54] Chen C, Jiang J, Lü JM, et al.Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells.Am J Physiol Heart Circ Physiol, 0,9(1):H 193-201.
    [55] Bowers MC, Hargrove LA, Kelly KA, et al.Tetrahydrobiopterin attenuates superoxide-induced reduction in nitric oxide.Frontiers in Bioscience, 1,3:1 263-272.
    [56] Rabelink, Ton J, Luscher, et al.Endothelial nitric oxide synthase:Host defense enzyme of the endothelium.Arterioscler Thromb Vasc Biol, 6,6(2):267-271.
    [57] Rekka EA, Chrysselis MC.Nitric oxide in atherosclerosis.Mini Rev Med Chem, 2,2(6):585-593.
    [58] Kaesemeyer WH, Caldwell RW.Atherosclerosis and nitric oxide production.Circulation, 0,2(11):e90-e90.
    [59] 李妍妍.一氧化氮与心血管疾病研究进展.国际内科学杂志, 2,9(10):426-430.
    [60] 尚改萍, 文志斌, 何晓凡, 等.补阳还五汤抗家兔动脉粥样硬化形成及机制.中国动脉硬化杂志, 2,0(2):112-114.
    [61] 孙学刚, 赵益业, 蔡宇, 等.补阳还五汤对动脉粥样硬化小鼠诱导型一氧化氮合酶表达的影响.中药药理与临床, 6,2(1):9-11.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

ZHU Bo-Ran, WU Hao-Xin. Research progress of Buyanghuanwu decoction on mechanism of anti-atherosclerosis[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2017,25(1):99-104.

Copy
Share
Article Metrics
  • Abstract:1165
  • PDF: 1079
  • HTML: 0
  • Cited by: 0
History
  • Received:February 19,2016
  • Revised:June 27,2016
  • Online: February 08,2017
Article QR Code

You are the 45579 visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025